Shares of Biotech Acquisition (OTCMKTS:BIOTU – Get Free Report) fell 7.7% on Friday. The stock traded as low as $10.14 and last traded at $10.14. 1,300 shares were traded during mid-day trading, a decline of 71% from the average session volume of 4,444 shares. The stock had previously closed at $10.98.
Biotech Acquisition Trading Down 7.7%
The firm’s fifty day moving average is $10.14 and its 200-day moving average is $10.14.
About Biotech Acquisition
Biotech Acquisition Company does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or other business combination with one or more businesses. The company was incorporated in 2020 and is based in New York, New York.
Recommended Stories
- Five stocks we like better than Biotech Acquisition
- AST SpaceMobile’s BlueBird Progress Comes With Several Risks Still Unresolved
- Time to Nibble on MCD Stock After it Enters Oversold Territory?
- McCormick Stock Trades Cheap, Offers Dividend Growth and Unilever Deal Upside
- Corning and AT&T’s $3 Billion Fiber Deal Reveals Where AI Spending Goes Next
Receive News & Ratings for Biotech Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Biotech Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.
